Why insider trading matters?

When insiders buy shares on the open market, this can thus be regarded as a strong endorsement by those that know the company the best -- they are literally betting their own money on the company's future. Insider selling, however, is not necessarily meaningful in any way, as there is a range of reasons for insiders to liquidate (some) of the shares they own.

- Seeking Alpha
Wave Life Sciences Ltd. (WVE)
Sector: Healthcare; Industry: Biotechnology

Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces of novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. The company is primarily developing oligonucleotides that target genetic defects to either reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins. Wave Life Sciences Ltd. was founded in 2012 and is based in Singapore.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-02-16 Francis Chris nan Sell 2,698 $10.57 $28,518 Yes
2021-02-16 BOLNO PAUL President and CEO Sell 11,205 $10.57 $118,437 Yes
2021-02-16 Panzara Michael A. nan Sell 2,929 $10.57 $30,960 Yes
2021-02-16 Vargeese Chandra Chief Technology Officer Sell 3,145 $10.57 $33,243 Yes
2021-02-16 Moran Kyle Chief Financial Officer Sell 1,722 $10.57 $18,202 Yes
2020-09-15 BOLNO PAUL President and CEO Sell 100,000 $15.00 $1,500,000 Yes
2020-08-25 BOLNO PAUL President and CEO Sell 25,000 $12.00 $300,000 Yes
2020-07-02 BOLNO PAUL President and CEO Sell 147,577 $10.30 $1,520,276 Yes
2020-02-18 Panzara Michael A. Chief Medical Officer Sell 2,981 $7.85 $23,401 No
2020-02-18 BOLNO PAUL President and CEO Sell 11,451 $7.85 $89,890 No
2020-02-18 Francis Chris See Remarks Sell 2,708 $7.85 $21,258 No
2020-02-18 Vargeese Chandra Senior VP, Drug Discovery Sell 3,188 $7.85 $25,026 No
2020-02-03 Gaiero David G Interim CFO Sell 651 $7.00 $4,557 No
2019-12-03 Vargeese Chandra Senior VP, Drug Discovery Sell 6,000 $35.00 $210,000 Yes
2019-11-20 Verdine Gregory L. Director Sell 30,039 $30.63 $920,213 No
2019-07-05 Panzara Michael A. Chief Medical Officer Sell 3,058 $26.94 $82,368 No
2019-03-15 BOLNO PAUL President and CEO Sell 50,000 $45.48 $2,273,804 Yes
2019-03-11 Panzara Michael A. Franchise Lead, Neurology Sell 7,000 $48.00 $336,000 No
2019-02-19 Regnante Keith Chief Financial Officer Sell 1,298 $36.84 $47,818 No
2019-02-19 Panzara Michael A. Franchise Lead, Neurology Sell 1,837 $36.84 $67,674 No
2019-02-19 BOLNO PAUL President and CEO Sell 7,733 $36.40 $281,456 No
2019-02-19 Vargeese Chandra Senior VP, Drug Discovery Sell 2,055 $36.84 $75,706 No
2019-02-19 Francis Chris See Remarks Sell 1,709 $36.84 $62,959 No
2019-01-24 RA CAPITAL MANAGEMENT, LLC 10%-Owner, Director Buy 263,158 $38.00 $10,000,004 No
2018-11-14 Verdine Gregory L. Director Sell 15,000 $38.86 $582,849 No
2018-09-25 Francis Chris See Remarks Sell 11,575 $56.00 $648,200 Yes
2018-09-24 Regnante Keith Chief Financial Officer Sell 29,500 $55.00 $1,622,500 Yes
2018-09-24 Vargeese Chandra Senior VP, Drug Discovery Sell 3,000 $55.00 $165,000 Yes
2018-07-09 Francis Chris See Remarks Sell 24,496 $37.27 $913,054 Yes
2018-06-01 Francis Chris See Remarks Sell 48,992 $46.75 $2,290,376 Yes

Insider Smart

Upwork Inc (UPWK) - GRETSCH GREGORY C. Director of Upwork, made a bulk buy of 500K shares right before the big gap up, which is also the largest buy of the past 12 months.

Insider Smart

Edesa Biotech, Inc. (EDSA) - President and CEO bought shares of EDSA in late May around $3, two weeks after their purchase, the stock jump to $9, very well timed buy.